As we look ahead to 2026, MedFriend enters the year with clarity of purpose and momentum across both consulting and digital health delivery. What began as a focused life sciences and digital health consultancy is evolving into a broader European platform, combining strategic advisory services with technology designed to make healthcare and clinical research more accessible, efficient, and patient-centric.

The year ahead is not about reinvention. It is about execution, scale, and maturity.

Expanding Our Consulting Footprint Across Europe

Consulting remains the foundation of MedFriend. In 2026, our primary focus is structured expansion across the EU, supporting life sciences, biotech, medtech, and digital health companies as they navigate increasingly complex regulatory, operational, and commercial environments.

Our consulting work will continue to centre on:

• Clinical research strategy and CRO selection
• Go-to-market planning for the UK and EU
• Vendor and procurement optimisation
• Market access and early commercialisation strategy
• Operational readiness for scale, audits, and partnerships

As European markets converge while regulations diverge, companies increasingly need advisors who understand local nuance with international perspective. MedFriend’s cross-border experience positions us to support clients entering new markets, restructuring operations, or preparing for the next stage of growth.

In 2026, we aim to deepen long-term partnerships rather than transactional engagements, embedding ourselves earlier in the decision-making process and supporting clients across full project lifecycles.

Team Expansion to Support Scale and Specialisation

Growth requires people. One of MedFriend’s key objectives for 2026 is measured team expansion, ensuring we scale without compromising quality, responsiveness, or expertise.

This includes:

• Expanding our analyst and project support capacity
• Strengthening regulatory and market access expertise
• Increasing delivery bandwidth for parallel consulting engagements
• Preparing internal capacity for platform and product growth

Rather than rapid headcount growth, our focus is on specialisation and operational resilience, building a team that can support both consulting clients and platform users with consistency and depth.

Launching the MedFriend Health App in Early Q2

A defining milestone for 2026 is the launch of the MedFriend digital health platform in early Q2.

The MedFriend app is designed to support secure, compliant online clinical services, including video consultations, patient record access, and digital interaction between patients and healthcare professionals. Built with privacy, usability, and regulatory alignment at its core, the platform reflects our belief that digital health should be practical, interoperable, and clinically meaningful.

The initial launch phase will focus on:

• Core functionality and user experience
• Secure handling of patient data within EU infrastructure
• Collaboration with healthcare partners and insurers
• Controlled rollout to ensure quality and stability

This is not technology for technology’s sake. The platform is designed to support real clinical workflows, reduce friction for patients, and create a scalable foundation for future services, including decentralised clinical trial support.

Strengthening Compliance, Governance, and Trust

As MedFriend grows across consulting and digital health, governance and compliance remain non-negotiable priorities.

In 2026, we continue to invest in:

• GDPR-aligned data protection and information security
• Structured quality management processes
• Document control, change management, and risk assessment
• Vendor oversight and third-party governance

Trust is central to everything we do. Whether advising a biotech company or handling patient data, MedFriend is committed to operating with transparency, accountability, and long-term credibility.

Thought Leadership and Strategic Visibility

Alongside delivery and product growth, 2026 will see a stronger emphasis on thought leadership and strategic visibility.

This includes:

• Publishing strategic insights on clinical operations and digital health
• Sharing practical guidance on CRO selection and vendor management
• Participating in industry discussions, panels, and events
• Strengthening our voice across LinkedIn and owned media

Our aim is not volume, but relevance. Content that reflects real experience, real challenges, and real solutions.

A Year of Execution

2026 is a year of execution for MedFriend. Expanding our consulting footprint across Europe. Growing the team with intent. Launching a digital health platform built for real-world use. Strengthening governance and long-term trust.

Get in Touch

If you are planning growth, preparing for clinical activity, or exploring digital health solutions in 2026, we would be glad to speak. Feel free to contact us at info@medfriend.health